(a) By July 1, 2019, the department, in collaboration with other agencies, departments, advocates, experts, health care service plan representatives, and other entities and stakeholders that it deems appropriate, shall convene a Task Force on Pharmacy Benefit Management Reporting to determine what information related to pharmaceutical costs, if any, the department should require to be reported by health care service plans or their contracted pharmacy benefit managers, in addition to reporting required by Section 1367.243. The task force shall consider inclusion of information including, but not limited to, the following:

(1) Wholesale acquisition costs of pharmaceuticals.

(2) Rebates obtained by the health care service plan or the pharmacy benefit manager from pharmaceutical manufacturers.

(3) Payments to network pharmacies.

(4) Exclusivity arrangements between health care service plans or contracted pharmacy benefit managers with pharmaceutical manufacturers.

(b) The task force shall consider the results of information reporting pursuant to Section 1367.243 and Chapter 9 (commencing with Section 127675) of Part 2 of Division 107 in determining what information should be reported pursuant to subdivision (a).

(c) The department shall submit a report of the Task Force on Pharmacy Benefit Management Reporting to the President pro Tempore of the Senate, the Speaker of the Assembly, and the Senate and Assembly Committees on Health, with the recommendations of the task force no later than February 1, 2020, on which date the task force shall cease to exist.

(d) This section shall become inoperative on February 1, 2020, and, as of January 1, 2021, is repealed.

(Added by Stats. 2018, Ch. 905, Sec. 4. (AB 315) Effective January 1, 2019. Section inoperative February 1, 2020. Repealed as of January 1, 2021, by its own provisions.)